Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, Mekinist 2 mg film-coated tablets, DRB436, DRB436, DRB436, TMT212
Novartis Pharmaceuticals
Multiple indications
1 trial -
TPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
ITP
1 trial -
TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.
LEO Pharma A/S
Atopic dermatitis and moderate-to severe atopic hand eczema
1 trial -
TYRX™ Absorbable Antibacterial Envelope
Rhythm Pharmaceuticals Netherlands B.V.
CIED Related Infection
1 trial -
Taneasy 600mg granules
Biotech Pharmaceutical Co.,
COPD (Chronic Obstructive Pulmonary Disease)
1 trial -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
11 trials -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Cystic Fibrosis
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Subarachnoid Hemorrhage, Aneurysmal
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Asthma
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy People
1 trial -
The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Incident dementia
1 trial -
The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension
AstraZeneca AB
Chronic Obstructive Pulmonary Disease
1 trial -
The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab
Lacuna Pharma Pty Ltd
Functional Dyspepsia
1 trial -
Ticagrelor followed with Methoxyflurane
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina
1 trial -
Tirzepatide
Grace Therapeutics
Prader-Willi Syndrome
1 trial -
Tolvaptan
Otsuka Beijing Research Institute
Hyponatremia and Extracellular Fluid in Cirrhotic
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
Tramadol HCI/acetaminophen
Janssen-Cilag Pty Ltd
Cancer
1 trial -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
Typhoid Vi vaccine
International Peace Maternity and Child Health Hospital
Typhoid
1 trial -
Use of an Implantable Loop Recorder
Rhythm Pharmaceuticals Netherlands B.V.
Syncope
1 trial -
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg
Pfizer Australia Pty Ltd
Migraine attacks with or without aura
1 trial -
Vedolizumab Placebo
Takeda
Pouchitis
1 trial -
WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL
Fondazione Telethon ETS
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources